(Q44328127)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605659%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Long-term hydroxyurea therapy in beta-thalassaemia patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605659%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605659%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

Carmen Silvia Passos Lima

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605659%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Valder Roberval Arruda

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605659%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Fernando Lopes Alberto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605659%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Sara Teresinha Ollala Saad

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605659%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Fernando Ferreira Costa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605659%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605659%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Haematology

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605659%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605659%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605659%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

151-155

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605659%20AND%20SRC:MED&resulttype=core&format=json

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00037.X

Regression of extramedullary haemopoiesis and augmentation of fetal haemoglobin concentration during hydroxyurea therapy in beta thalassaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00037.X

Hydroxyurea and sodium phenylbutyrate therapy in thalassemia intermedia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00037.X

Treatment with hydroxyurea in thalassemia intermedia with paravertebral pseudotumors of extramedullary hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00037.X

Five years of experience with hydroxyurea in children and young adults with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00037.X

Brief report: treatment with azacitidine of patients with end-stage beta-thalassemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00037.X

Successful use of hydroxyurea in beta-thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00037.X

Hydroxyurea therapy in paraparesis and cauda equina syndrome due to extramedullary haematopoiesis in thalassaemia: improvement of clinical and haematological parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00037.X

beta0-thalassemia resulting from a novel mutation: beta66/u-->stop codon

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00037.X

Pharmacological induction of fetal hemoglobin in sickle cell disease and beta-thalassemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00037.X

7 January 2021

5-Azacytidine Selectively Increases γ-Globin Synthesis in a Patient with β+Thalassemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00037.X

7 January 2021

Minimal doses of hydroxyurea for sickle cell disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00037.X

7 January 2021

Pharmacological manipulation of fetal hemoglobin synthesis in patients with severe beta-thalassemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00037.X

7 January 2021

Pharmacologic treatment of thalassemia intermedia with hydroxyurea

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00037.X

7 January 2021

Hydroxyurea therapy in β‐thalassaemia intermedia: improvement in haematological parameters due to enhanced β‐globin synthesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00037.X

7 January 2021

Hydroxyurea therapy in thalassemia.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00037.X

7 January 2021

Preliminary report: hydroxyurea produces significant clinical response in thalassemia intermedia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00037.X

7 January 2021

Hemoglobin switching protocols in thalassemia. Experience with sodium phenylbutyrate and hydroxyurea.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00037.X

7 January 2021

10.1034/J.1600-0609.2003.00037.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605659%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference